Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
272 studies found for:    cholangiocarcinoma
Show Display Options
Rank Status Study
1 Completed
Has Results
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: CT scan
2 Active, not recruiting A Phase II Study of Cabozantinib (XL-184) Monotherapy in Patients With Advanced Cholangiocarcinoma After Progression on First or Second Line Systemic Therapy
Conditions: Bile Duct Cancer;   Intrahepatic Cholangiocarcinoma;   Cholangiocarcinoma of the Extrahepatic Bile Duct
Intervention: Drug: Cabozantinib
3 Recruiting Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: FOLFIRINOX
4 Recruiting Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
Conditions: Intrahepatic Cholangiocarcinoma;   Mixed Hepatocellular Cholangiocarcinoma;   Cholangiocarcinoma
Intervention:
5 Unknown  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition: Advanced Intrahepatic Cholangiocarcinoma
Intervention: Drug: Calcitriol
6 Unknown  Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Everolimus
7 Completed S-1 and Photodynamic Therapy in Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: S-1 Chemotherapy;   Procedure: Photodynamic therapy;   Procedure: Systemic chemotherapy except S-1
8 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy
9 Completed Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine
10 Unknown  Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Condition: Unresectable Hilar Cholangiocarcinoma
Intervention: Device: biliary stent
11 Recruiting Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Other: exposure to different risk factors and molecular assessment
12 Completed Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
Conditions: Cholangiocarcinoma;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin
13 Unknown  Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Drainage;   Surgery
Intervention: Procedure: Preoperative biliary drainage
14 Withdrawn Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Condition: Cholangiocarcinoma
Intervention:
15 Recruiting Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Procedure: conventional lymph node dissection;   Procedure: unconventional lymph node dissection
16 Terminated
Has Results
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation
17 Recruiting Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Condition: Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Intervention: Drug: H3B-6527
18 Recruiting Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
19 Recruiting International Registry on Cholangiocarcinoma Treatment
Condition: Cholangiocarcinoma
Intervention: Drug: Doxorubicin
20 Terminated Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: WST11

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years